Brief: Endra Life Sciences Inc Says Expects No Revenue For Quarter Ended March 31, 2023
18/04/2023 14:13
April 18 (Reuters) - ENDRA Life Sciences Inc NDRA.O :
* ENDRA LIFE SCIENCES INC SAYS EXPECTS NO REVENUE FOR
QUARTER
ENDED MARCH 31, 2023
* ENDRA LIFE SCIENCES INC SAYS EXPECTS TO RECORD NET LOSS OF
ABOUT
$2.8 MILLION FOR QUARTER ENDED MARCH 31, 2023
Source text for Eikon: ID:
Further company coverage: NDRA.O
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences